SCHEMBL3473032

SCHEMBL3473032

CN(N)c1cc(=O)n(-c2ccccc2)c(=O)[nH]1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 9/20 0.49
LMNA P02545 2/20 0.49
GAA P10253 3/20 0.47
HSD17B10 Q99714 2/20 0.46
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
KDM4C Q9H3R0 2/20 0.43
HPGD P15428 2/20 0.43
SMN1; SMN2 Q16637 1/20 0.42
GSK3A P49840 1/20 0.42
GSK3B P49841 1/20 0.42
KDM4E B2RXH2 2/20 0.41
MEN1 O00255 2/20 0.40
KMT2A Q03164 2/20 0.40
L3MBTL1 Q9Y468 1/20 0.40
NTRK1 P04629 2/20 0.39
IGF1R P08069 2/20 0.39
FGFR1 P11362 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3471967 0.79 ALDH1A1 (0.50) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL14450252 0.78 L3MBTL1 (0.39) ALDH1A1GAAHSD17B10TSHRHTT
SCHEMBL3473567 0.77 HPGD (0.51) ALDH1A1GAAKDM4CHPGDSMN1; SMN2
SCHEMBL1945403 0.75 ALDH1A1 (0.55) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL9652503 0.75 SMN1; SMN2 (0.70) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL2183881 0.73 GAA (0.58) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL3472829 0.71 ALDH1A1 (0.55) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL13143119 0.71 ALDH1A1 (0.55) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL11614830 0.71 ALDH1A1 (0.51) ALDH1A1LMNAGAAHSD17B10TSHR
SCHEMBL13534958 0.71 ALDH1A1 (0.57) ALDH1A1LMNAGAAHSD17B10TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010072807-A2 INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE FONDATION JEROME LEJEUNE (FR) 2010-07-01 WO disclosed